ArticleEuropean journal of clinical pharmacology2026
Comment on "CYP2C19 genotyping and mavacamten: predicting outcomes in normal, intermediate and rapid metabolisers in obstructive hypertrophic cardiomyopathy".
Kotina Shridevi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.